Cardiometabolic Health Congress (CMHC)
M

Navigating the Web of the Prescription Approval and Appeals Process: A Case Study with PCSK9i

By Cardiometabolic Health Congress (CMHC) FEATURING Matthew Stryker
By Cardiometabolic Health Congress (CMHC) FEATURING Matthew Stryker
0 views
October 22, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

48:22
Lilly Diabetes

A Journey Through Clinical Efficacy and Safety Data Comparing Two T2…

Feat. B. Hirsch

Featured Video

15:01
Lilly Diabetes

Discover the MOA of an Incretin Medication for T2D

Recommended

AUTOPLAY
National Jewish Health

47th Annual Pulmonary and Allergy Update

Wed, Feb 5, 2025
See 1 other
Transformative Endovascular Decisions Conference

Transformative Endovascular Decisions 2025

Sat, Feb 22, 2025
American Academy of Anti-Aging Medicine

LongevityFest 2024

Fri, Dec 13, 2024
American Society of Nuclear Cardiology

Cardiac PET Advanced Virtual Workshop

Sat, Dec 7, 2024
Cardiovascular Computed Tomography TV by SCCT

Virtual CT in CHD: Advanced Workstation Course

Sat, Dec 7, 2024
See 1 other
International Psoriasis Council (IPC)

Psoriasis: From Gene to Clinic International Congress

Thu, Dec 5, 2024
ISAKOS

2025 ISAKOS Congress

Sun, Jun 8, 2025
ISHA - The Hip Preservation Society

ISHA 2025 Annual Scientific Meeting

Thu, Oct 2, 2025
See 1 other
LivDerm

South Beach Symposium 2025

Thu, Feb 6, 2025
Society for Cardiovascular Angiography & Interventions (SCAI)

SCAI 2025 Scientific Sessions

Thu, May 1, 2025
13:00
OJM Group

Put Your Best Tax Foot Forward: Qualified Retirement Plans for Physi…

Feat. A. Braunscheidel
12:04
Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

82:32
Codman Shoulder Society

Basic Accounting for Physicians: What Skills Do You Need to Have to …

Feat. J. Warner
59:01
The North American Thrombosis Forum (NATF)

Recent Cholesterol Guidelines and Integration into Clinical Practice

Feat. J. Plutzky, L. Braun, J. Ross
18:43
Canadian Collaborative Research Network

Lp(a): When to Measure it and What to Do About it

Feat. M. O'Donoghue
08:44
AHA 2022 Conference Coverage

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

Feat. N. Marston
21:27
Scripps Health

Lipids Update: Current Guidelines for Lipid Management

Feat. S. R. Mehta
14:50
AHA 2022 Conference Coverage

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

Feat. K. Ray
24:02
Complex Coronary Cases

Updated Lipid Guidelines and Therapy

Feat. I. Fergus
45:45
Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald
31:02
Scripps Health

How Do I Reverse Coronary Plaque?

Feat. C. J. Suhar
19:48
ACC 2022 Conference Coverage

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "…

Feat. R. Giugliano
39:44
The Texas Heart Institute

Lipid Lowering Therapies: Where Did We Start, Where We Are Now and W…

Feat. S. Virani
33:43
Jefferson Health

Update on Lipids: Current Options for Lowering LDL to Reduce CV Risk

Feat. A. Cohen
25:02
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

How to Reduce Cholesterol and Triglycerides to Prevent CV Events

Feat. P. Taub
27:12
Norman Lepor

Update on Lipoprotein A: The Horrible Cholesterol

07:19
CVRx | Barostim

Considering Quality of Life as Part of Patient Selection for Heart F…

Feat. L. Grazette
31:50
Nadir Ali

Do Statins Prevent or Cause Heart Disease? Should LDL Be Called &quo…

20:44
MUSC Cardiology

Big Questions About Lipoprotein “Little” (a)

Feat. A. Arana Waring
12:50
AVA at Your Fingertips

Lessons Learned From Trials of Implementation: The CLABSI Section of…

Feat. V. Chopra